Filing Manager
22NW Fund, LP
Reporting Manager
22NW Fund, LP
Symbol
LFCR
Shares outstanding
39,346,838 shares
Disclosed Ownership
4,367,499 shares
Ownership
11%
Form type
SCHEDULE 13D/A
Filing time
26 Dec 2024, 13:20:34 UTC
Date of event
23 Dec 2024
Next filing
29 May 2025

Quoteable Key Fact

"22NW Fund, LP disclosed 11% ownership in Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR) on 23 Dec 2024."

Quick Takeaways

  • 22NW Fund, LP filed SCHEDULE 13D/A for Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR).
  • Disclosed ownership: 11%.
  • Date of event: 23 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 26 Dec 2024, 13:20.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
22NW Fund, LP 11% 4,367,499 4,367,499 0 22NW Fund GP, LLC General Partner 0001640809
22NW, LP 11% 4,367,499 4,367,499 0 22NW GP, Inc., General Partner 0001694297
22NW Fund GP, LLC 11% 4,367,499 4,367,499 0 /s/ Aron R. English Manager 0001770575
22NW GP, Inc. 11% 4,367,499 4,367,499 0 /s/ Aron R. English President and Sole Shareholder 0001783663
Aron R. English 11% 4,367,499 4,367,499 0 /s/ Aron R. English Individually and as attorney-in-fact for Nathaniel Calloway 0001770436
Bryson O. Hirai-Hadley 0% 583 583 0 /s/ Bryson O. Hirai-Hadley Bryson O. Hirai-Hadley 0001888106
Nathaniel Calloway 0% 34,315 34,315 0 /s/ Aron R. English As attorney-in-fact for Nathaniel Calloway 0001952771
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .